ASND
Price
$146.59
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
49 days until earnings call
ATHA
Price
$0.49
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
50 days until earnings call
Ad is loading...

ASND vs ATHA

Header iconASND vs ATHA Comparison
Open Charts ASND vs ATHABanner chart's image
Ascendis Pharma A/S
Price$146.59
Change-$0.00 (-0.00%)
Volume$1.99M
CapitalizationN/A
Athira Pharma
Price$0.49
Change-$0.00 (-0.00%)
Volume$1.14M
CapitalizationN/A
View a ticker or compare two or three
ASND vs ATHA Comparison Chart
Loading...
ASND
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ATHA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ASND vs. ATHA commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a StrongBuy and ATHA is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (ASND: $146.59 vs. ATHA: $0.49)
Brand notoriety: ASND and ATHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 329% vs. ATHA: 126%
Market capitalization -- ASND: $8.41B vs. ATHA: $18.67M
ASND [@Biotechnology] is valued at $8.41B. ATHA’s [@Biotechnology] market capitalization is $18.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 0 FA rating(s) are green whileATHA’s FA Score has 1 green FA rating(s).

  • ASND’s FA Score: 0 green, 5 red.
  • ATHA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ASND and ATHA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 7 TA indicator(s) are bullish while ATHA’s TA Score has 4 bullish TA indicator(s).

  • ASND’s TA Score: 7 bullish, 4 bearish.
  • ATHA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ASND is a better buy in the short-term than ATHA.

Price Growth

ASND (@Biotechnology) experienced а +27.74% price change this week, while ATHA (@Biotechnology) price change was -0.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

ASND is expected to report earnings on Nov 06, 2024.

ATHA is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($8.41B) has a higher market cap than ATHA($18.7M). ASND YTD gains are higher at: 16.387 vs. ATHA (-80.008). ATHA has higher annual earnings (EBITDA): -120.43M vs. ASND (-362.83M). ASND has more cash in the bank: 320M vs. ATHA (91.8M). ATHA has less debt than ASND: ATHA (1.41M) vs ASND (669M). ASND has higher revenues than ATHA: ASND (329M) vs ATHA (0).
ASNDATHAASND / ATHA
Capitalization8.41B18.7M44,957%
EBITDA-362.83M-120.43M301%
Gain YTD16.387-80.008-20%
P/E RatioN/AN/A-
Revenue329M0-
Total Cash320M91.8M349%
Total Debt669M1.41M47,548%
FUNDAMENTALS RATINGS
ASND: Fundamental Ratings
ASND
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASNDATHA
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ASND
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ATHA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHGE1.020.03
+3.54%
BiomX Inc
PLXS127.841.21
+0.96%
Plexus Corp
ITI7.110.01
+0.14%
Iteris
BFS40.28-0.43
-1.06%
Saul Centers
INVH36.11-0.66
-1.79%
Invitation Homes

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with OGEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
-3.99%
OGEN - ATHA
36%
Loosely correlated
+0.80%
ALNY - ATHA
35%
Loosely correlated
+1.51%
PCVX - ATHA
33%
Poorly correlated
+2.20%
MNKD - ATHA
32%
Poorly correlated
+0.15%
ASND - ATHA
32%
Poorly correlated
+5.03%
More